Shawn T. McCormick's Insider Trades & SAST Disclosures
Shawn T. McCormick's most recent trade in Inspire Medical Systems Inc was a trade of 1,266 Common Stock done . Disclosure was reported to the exchange on May 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Shawn T. McCormick.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 1,266 | 24,406 (0%) | 0% | 0 | Common Stock | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Sale of securities on an exchange or to another person at price $ 160.00 per share. | 01 May 2025 | 360 | 24,046 (0%) | 0% | 160 | 57,600 | Common Stock |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Sale of securities on an exchange or to another person at price $ 220.00 per share. | 09 Sep 2024 | 800 | 23,140 (0%) | 0% | 220 | 176,000 | Common Stock |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.94 per share. | 14 Aug 2024 | 8,537 | 23,940 (0%) | 0% | 0.9 | 8,025 | Common Stock |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 7,518 | 0 | - | - | Stock Option (Right to Buy) | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Aug 2024 | 1,019 | 0 | - | - | Stock Option (Right to Buy) | |
| Nevro Corp | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 19,169 | 46,035 (0%) | 0% | 0 | Common Stock | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2024 | 2,500 | 1,019 | - | - | Stock Option (Right to Buy) | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.94 per share. | 10 May 2024 | 2,500 | 15,403 (0%) | 0% | 0.9 | 2,350 | Common Stock |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 716 | 12,903 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Shawn T. McCormick | Director | Purchase of securities on an exchange or from another person at price $ 22.88 per share. | 07 Jun 2023 | 7,500 | 26,866 (0%) | 0% | 22.9 | 171,633 | Common Stock |
| Nevro Corp | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 6,754 | 19,366 (0%) | 0% | 0 | Common Stock | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 669 | 12,187 (0%) | 0% | 0 | Common Stock | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Mar 2023 | 4,000 | 3,519 | - | - | Stock Option (Right to Buy) | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.94 per share. | 17 Mar 2023 | 4,000 | 11,518 (0%) | 0% | 0.9 | 3,760 | Common Stock |
| Nevro Corp | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,155 | 12,612 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 4,155 | 12,612 (0%) | 0% | 0 | Common Stock | |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 1,243 | 1,243 | - | - | Stock Option (right to buy) | |
| Nevro Corp | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2021 | 1,167 | 8,457 (0%) | 0% | 0 | Common Stock | |
| Nevro Corp | Shawn T. McCormick | Director | Sale of securities on an exchange or to another person at price $ 149.65 per share. | 24 May 2021 | 482 | 7,290 (0%) | 0% | 149.6 | 72,131 | Common Stock |
| Inspire Medical Systems Inc | Shawn T. McCormick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 1,175 | 1,175 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges